Beware of posters who compare Veyonda results to those achieved elsewhere, but (deliberately?) fail to note that the other patients had a newer disease state.
The best apple-to-apple comparison is with St Vincent's patients treated by Louise Emmett, whose patients received LuPSMA alone; or with Veyonda. Same hospital, same doctors, same types of patients, same treatment protocol, vastly different results.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.63M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 47773 | 9.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.9¢ | 90000 | 1 |
View Market Depth
| Last trade - 09.59am 15/09/2025 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable